Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,334
datasets available to search
ShareScore release 0.9.0
Dataset results
1,334 results for “Hematology”
Targeting of the CD161 Inhibitory Receptor Enhances T cell-mediated Immunity Against Hematological Malignancies
GEO Series GSE220200. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Timing of Ezh2Y641F mutation determines oncogenic and molecular outcomes in hematologic diseases
GEO Series GSE270480. Mus musculus. 21 samples. Type: Expression profiling by high throughput sequencing.
Activity of EP300/CBP bromodomain inhibitor CCS1477 across diverse hematologic malignancies (ATAC-Seq)
GEO Series GSE207355. Homo sapiens. 8 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Activity of EP300/CBP bromodomain inhibitor CCS1477 across diverse hematologic malignancies (RNA-Seq)
GEO Series GSE207353. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [array]
GEO Series GSE78517. Homo sapiens. 6 samples. Type: Expression profiling by array.
Activity of EP300/CBP bromodomain inhibitor CCS1477 across diverse hematologic malignancies (ChIP-Seq)
GEO Series GSE207354. Homo sapiens. 61 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties
GEO Series GSE121266. Homo sapiens. 8 samples. Type: Expression profiling by array.
Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression
Open the record for dataset details and reuse information.
Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
ClinicalTrials.gov study NCT07131449. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology Unit
ClinicalTrials.gov study NCT05119205. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy
ClinicalTrials.gov study NCT07198958. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
ClinicalTrials.gov study NCT07362602. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Wh
ClinicalTrials.gov study NCT00341055. IPD Sharing: Not stated. Countries: 0. Publications: 0.
HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
ClinicalTrials.gov study NCT07175415. IPD Sharing: NO. Countries: 0. Publications: 0.
Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness
ClinicalTrials.gov study NCT06674330. IPD Sharing: NO. Countries: 0. Publications: 0.
Precision Physical Exercise for Personalized Onco-Hematology.
ClinicalTrials.gov study NCT07286539. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis
ClinicalTrials.gov study NCT07111416. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic Malignancies
ClinicalTrials.gov study NCT00666081. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Fungal Infections in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT03650439. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
ClinicalTrials.gov study NCT07107204. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.